Last reviewed · How we verify
NCT03963089
Effect of Tidal Volume Change on Pressure-based Prediction of Fluid Responsiveness in Children
NA trial testing Tidal volume_6mL/kg in Plasma Volume in 30 participants. Completed in 6 October 2020.
23 June 2020
Quick facts
| Lead sponsor | Seoul National University Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | screening |
| Enrollment | 30 |
| Start date | 30 May 2019 |
| Primary completion | 23 June 2020 |
| Estimated completion | 6 October 2020 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- Tidal volume_6mL/kg
- Tidal volume_10mL/kg
- Tidal volume_14mL/kg
- Fluid loading
Conditions studied
- Plasma Volume — all drugs for Plasma Volume →
- Tidal Volume — all drugs for Tidal Volume →
Sponsor
Seoul National University Hospital
Who can join
Under 5, any sex, with Plasma Volume or Tidal Volume. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study evaluates predictability of fluid responsiveness of pressure-based dynamic variables such as pulse pressure variation and systolic pressure variation, according to tidal volume change in patients undergoing cardiac surgery.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03963089
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Plasma Volume
Currently open trials in the same condition.
- NCT07118462 — HighCycle Study: Acetazolamide, High Altitude and Plasma Volume · Phase 4 · recruiting
Other Seoul National University Hospital trials
Trials by the same sponsor.
- NCT07262944 — EOI Block in Otoplasty With Rib Cartilage Graft · NA · recruiting
- NCT07464210 — Nemtabrutinib, Bortezomib, and Rituximab for WM · Phase 2 · not yet recruiting
- NCT07550803 — Effect of Intraoperative Dexamethasone on Early Postoperative Sleep Quality in Patients Undergoing Nasal Surgery · NA · not yet recruiting
- NCT07522138 — Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study · NA · not yet recruiting
- NCT07476651 — Scout Dose of Resin Microspheres · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03963089 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Seoul National University Hospital
- Last refreshed: 5 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03963089.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing